BioStem Technologies Initiates Nationwide Launch of Vendaje AC(R) with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
POMPANO BEACH, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces it will initiate a nationwide launch of Vendaje AC(R) with Venture Medical, LLC, the Company’s exclusive sales and marketing partner. The launch […]